Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 5 Breast 5 Other hematologic neoplasm 3 Gastrointestinal 2 Endocrine 2 Gynecologic 1 CNS 1

Conditions

Brain Neoplasms 1702 Glioblastoma 1308 Glioma 995 Neuroblastoma 408 Central Nervous System Neoplasms 384 Astrocytoma 384 Gliosarcoma 286 Oligodendroglioma 238 Neoplasms 226 Breast Neoplasms 216 Meningioma 179 Medulloblastoma 172 Carcinoma, Non-Small-Cell Lung 149 Recurrence 147 Neoplasm Metastasis 138 Lung Neoplasms 138 Ependymoma 128 Melanoma 119 Sarcoma 117 Neurofibromatosis 1 110 Meningeal Carcinomatosis 107 Lymphoma 95 Neuroma, Acoustic 82 Diffuse Intrinsic Pontine Glioma 81 Precursor Cell Lymphoblastic Leukemia-Lymphoma 79 Head and Neck Neoplasms 79 Ovarian Neoplasms 73 Lymphoma, Follicular 73 Pheochromocytoma 71 Paraganglioma 68

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hyperglycemia × CNS × Clear all

NCT03235934 2021-10-25

Glycemic Impact on Glioblastoma Outcomes

University Health Network, Toronto

Glioblastoma, Hyperglycemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡